1. Academic Validation
  2. mTOR-FABP4 signal is activated in brain arteriovenous malformations in humans

mTOR-FABP4 signal is activated in brain arteriovenous malformations in humans

  • J Mol Med (Berl). 2022 Sep;100(9):1287-1297. doi: 10.1007/s00109-022-02237-9.
Debin Yan 1 Qiang Hao 1 Yu Chen 1 Zhipeng Li 1 Haibin Zhang 1 Kexin Yuan 1 Runting Li 1 Ruinan Li 1 Yahui Zhao 1 Ke Wang 1 Hao Peng 2 Dong Zhang 3 Xiaolin Chen 4 Yuanli Zhao 5 6 7 8 9 10
Affiliations

Affiliations

  • 1 Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • 2 Hainan General Hospital, Hainan, China.
  • 3 Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. [email protected].
  • 4 Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. [email protected].
  • 5 Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. [email protected].
  • 6 Department of Neurosurgery, Peking University International Hospital, Peking University, Beijing, China. [email protected].
  • 7 China National Clinical Research Center for Neurological Diseases, Beijing, China. [email protected].
  • 8 Stroke Center, Beijing Institute for Brain Disorders, Beijing, China. [email protected].
  • 9 Beijing Key Laboratory of Translation Medicine for Cerebrovascular Disease, Beijing, China. [email protected].
  • 10 Beijing Translational Engineering Enter for 3D Printer in Clinical Neuroscience, Beijing, China. [email protected].
Abstract

Arteriovenous malformations (AVMs) are the most common types of cerebral vascular malformations, which are dynamic lesions with de novo growth potentials. The dysfunction of endothelial cells has been postulated to play a role in the pathogenesis of brain AVMs. mTOR-FABP4 signal enhances the angiogenic responses of endothelial cells and is not activated in the normal cerebral vasculature. Herein, we investigated the hypothesis that the mTOR-FABP4 signal may be activated in brain AVMs. The abundance of molecules in mTOR-FABP4 signal expression was detected by immunohistochemistry and Western blotting; special expressing cells were further characterized by double immunofluorescence using Antibodies against various cell-specific markers. Next, several functional assays were performed to analyze the influence of the mTOR-FABP4 signal on proliferation, Apoptosis, migration, and vascular tube formation of endothelial cells in human umbilical vein endothelial cells (HUVECs) using rapamycin and L-leucine. The expression of mTOR, p-mTOR, and FABP4 was increased in endothelial cells of human brain AVMs. Endothelial cell mTOR and p-mTOR expression were present in 70% and 55% of brain AVMs, respectively. Moreover, a population of FABP4-positive endothelial cells was detected in 80% of brain AVMs. The mTOR-FABP4 signal was activated and inhibited by L-leucine and rapamycin in HUVECs. The proliferation, Apoptosis, migration, and vascular tube formation of endothelial cells could be inhibited by rapamycin. The mTOR-FABP4 signal was activated in human brain AVMs, and the mTOR-FABP4 signal was involved in proliferation, Apoptosis, migration, and the vascular tube formation of endothelial cells. Taken together, whether rapamycin has therapeutic potential for treating human brain AVMs is worthy of further study. KEY MESSAGES : We confirmed that the mTOR- FABP4 pathway is activated in human brain arteriovenous malformations. We confirmed that mTOR signaling pathway affects endothelial cell function by regulating proliferation, migration, Apoptosis, and tube formation of endothelial cell. Our study can provide theoretical support for mTOR pathway inhibitors in the treatment of human brain arteriovenous malformations.

Keywords

Angiogenesis; Brain arteriovenous malformation; Endothelial cell; FABP4; mTOR.

Figures
Products